Advanced search
Publication Cover
Blood Pressure Volume 18, 2009 - Issue 1-2
Submit an article Journal homepage
1,221
Views
18
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension

Jiri Ceral Department of Internal Medicine, University Hospital Hradec Kralove, Charles University Prague, Medical Faculty, Hradec Kralove, Czech Republic
&
Miroslav Solar Department of Internal Medicine, University Hospital Hradec Kralove, Charles University Prague, Medical Faculty, Hradec Kralove, Czech RepublicCorrespondence[email protected]
Pages 74-77 | Received 03 Dec 2008, Published online: 08 Jul 2009

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maria Czarina Acelajado, David A Calhoun & Suzanne Oparil. (2009) Reduction of blood pressure in patients with treatment-resistant hypertension. Expert Opinion on Pharmacotherapy 10:18, pages 2959-2971.
Read now

Articles from other publishers (17)

Joseph William Clinton, Sara Kiparizoska, Soorya Aggarwal, Stephanie Woo, William Davis & James H. Lewis. (2021) Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature. Drug Safety 44:11, pages 1125-1149.
Crossref
Xiao Zhong, Xiaoqian Qian, Guangping Chen & Xiang Song. (2019) The role of galectin-3 in heart failure and cardiovascular disease. Clinical and Experimental Pharmacology and Physiology 46:3, pages 197-203.
Crossref
Hamish C.G. Prosser, Omar Azzam & Markus P. Schlaich. (2018) Resistant Hypertension: Which Agent?. Heart, Lung and Circulation 27:8, pages 911-916.
Crossref
Daniel Cervantes-Garcia, Adriana Guadalupe Cuellar-Juarez, Gissela Borrego-Soto, Augusto Rojas-Martinez, Liseth Rubi Aldaba-Muruato, Eva Salinas, Javier Ventura-Juarez & Martin Humberto Muñoz-Ortega. (2017) Adenoviral-bone morphogenetic protein-7 and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model. Molecular Medicine Reports 16:6, pages 9431-9440.
Crossref
Andrew Y. Hwang, Eric Dietrich, Carl J. Pepine & Steven M. Smith. (2017) Resistant Hypertension: Mechanisms and Treatment. Current Hypertension Reports 19:7.
Crossref
Hamish CG Prosser, Cynthia Gregory, Dagmara Hering, Graham S Hillis, Greg Perry, Johan Rosman, Carl Schultz, Mark Thomas, Gerald F Watts & Markus P Schlaich. (2017) Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?. Current Hypertension Reports 19:4.
Crossref
Xiaoqian Qian, Mingyang Li, Mary B. Wagner, Guangping Chen & Xiang Song. (2016) Doxazosin Stimulates Galectin-3 Expression and Collagen Synthesis in HL-1 Cardiomyocytes Independent of Protein Kinase C Pathway. Frontiers in Pharmacology 7.
Crossref
Talya Wolak, Ronen Toledano, Victor Novack, Amir Sharon, Aryeh Shalev & Arik Wolak. (2014) Doxazosin to treat hypertension. Journal of Hypertension 32:5, pages 1132-1137.
Crossref
Maria Czarina Acelajado & David A. Calhoun. 2013. Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease. Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease 501 509 .
Lourdes Gonzalez-Santos, William J. Elliott, John F. Setaro & Henry R. Black. 2013. Hypertension: A Companion to Braunwald’s Heart Disease. Hypertension: A Companion to Braunwald’s Heart Disease 378 384 .
Yuan Shao, Ran Chen, Zhou-jun Shen, Ying Teng, Peng Huang, Wen-bin Rui, Xin Xie & Wen-long Zhou. (2011) Preoperative alpha blockade for normotensive pheochromocytoma. Journal of Hypertension 29:12, pages 2429-2432.
Crossref
William J. Elliott. (2011) Management of Resistant Hypertension. Current Cardiovascular Risk Reports 5:5, pages 373-382.
Crossref
Robert Holaj. (2011) Management of resistant hypertension. Cor et Vasa 53:8-9, pages 423-428.
Crossref
Samuel J. Mann. (2011) Drug Therapy for Resistant Hypertension: Simplifying the Approach. The Journal of Clinical Hypertension 13:2, pages 120-130.
Crossref
Jamie J. Coleman, Anthony R. Cox & Nicholas J. Cowley. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 413 435 .
Monika LechleitnerFriedrich Hoppichler. (2010) Present and Prospective Clinical Therapeutic Options for the Elderly Patient with Hypertension. Clinical Medicine Insights: Therapeutics 2, pages CMT.S2110.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.